Senator Susan Collins has joined a group of fellow Senators trying to implement new measures called the Insulin Price Reduction Act. The goal of the legislature is to incentivize reduction on prices for Pharmaceutical and Insurance companies while also holding them more accountable according to WGME.

In a recent report, insulin costs have quadrupled since 2007 for medicare users, but with this new proposal, the Senators are hoping to create a new pricing model benefiting both Medicare and private insurance users.